Table 4.
Odds ratios (95% confidence intervals) of 40 months incident CKD (eGFR<60 ml/min per 1.73 m2) among patients without CKD at baseline according to intervention of Omega-3 fatty acids compared with placebo
| Treatment Groups | No CKD at baseline (N) | Incident CKD N (%) | Odds Ratio (95% CI) |
|---|---|---|---|
| Placebo | 500 | 83 (17) | 1 (reference) |
| ALA | 503 | 83 (17) | 0.99 (0.71 to 1.39) |
| EPA-DHA | 467 | 66 (14) | 0.83 (0.58 to 1.18) |
| EPA-DHA plus ALA | 468 | 65 (14) | 0.81 (0.57 to 1.15) |